Regarding a possible mechanism explaining the role of miR-34a in refractory CLL, Zenz and colleagues demonstrated that this miRNA altered both the resistance to apoptosis and the DNA Damage Response (DDR), even without 17p deletion or TP53 mutation [60]. This evidence concerns the gene TP53 and B-cell chronic lymphocytic leukemia.